Skip to main content
. 2019 May 10;21(8):1143–1144. doi: 10.1093/europace/euz132

Appendix 1.

Author disclosure table

Writing group member Employment Honoraria/Speaking/Consulting Speakers’ bureau Research* Fellowship support* Ownership/Partnership/Principal/Majority stockholder Stock or stock options Intellectual property/Royalties Other
Edmond M. Cronin, MB, BCh, BAO, FHRS, CCDS, CEPS-A (Chair) Hartford Hospital, Hartford, Connecticut None None None None None None None None
Frank M. Bogun, MD (Vice-Chair) University of Michigan, Ann Arbor, Michigan None None None None None None None None
Philippe Maury, MD (EHRA Chair) University Hospital Rangueil, Toulouse, France None None None None None None None None
Petr Peichl, MD, PhD (EHRA Vice-Chair) Institute for Clinical and Experimental Medicine, Prague, Czech Republic 1: Abbott; 1: Biosense Webster; 1: BIOTRONIK None None None None None None None
Minglong Chen, MD, PhD, FHRS (APHRS Chair) Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China None None None None None None None 0: APHRS Board Member
Narayanan Namboodiri, MBBS, MD (APHRS Vice-Chair) Sree Chitra Institute for Medical Sciences and Technology, Thiruvananthapuram, India None None None None None None None None
Luis Aguinaga, MD, PhD, FESC, FACC (LAHRS Chair) Centro Privado de Cardiología, Tucuman, Argentina None None None None None None None None
Luiz Roberto Leite, MD, PhD, FHRS (LAHRS Vice-Chair) Instituto Brasília de Arritmia, Brasília, Brazil None 1: Boehringer Ingelheim None None None None None None
Sana M. Al-Khatib, MD, MHS, FHRS, CCDS Duke University Medical Center, Durham, North Carolina None None None None None None None None
Elad Anter, MD Beth Israel Deaconess Medical Center, Boston, Massachusetts 2: Itamar Medical; 3: Boston Scientific; 4: Biosense Webster None None None None None None None
Antonio Berruezo, MD, PhD Heart Institute, Teknon Medical Center, Barcelona, Spain 1: Biosense Webster 1: Biosense Webster 2: Biosense Webster None None None None None
David J. Callans, MD, FHRS, CCDS University of Pennsylvania, Philadelphia, Pennsylvania 1: Abbott Laboratories; 1: BIOTRONIK; 1: Medtronic; 1: Wolters Kluwer; 2: Boston Scientific None 4: NIH 2: BIOTRONIK; 2: Boston Scientific; 4: Abbott; 4: Biosense Webster; 4: Medtronic None None None 1: Acutus Medical; 1: AtriCure; 1: Impulse Dynamics; 1: Thermedical; 3: Bayer
Mina K. Chung, MD, FHRS Cleveland Clinic, Cleveland, Ohio 2: ABIM None 5: AHA; 5: NIH None None None 1: Elsevier; 1: Up to Date 0: ACC (EP Section Leadership Council member); 0: AHA (Chair, ECG & Arrhythmias Committee; Member, Clinical Cardiology Leadership Committee; Member, Committee on Scientific Sessions Programming); 0: Amarin (Data monitoring committee member); 0: BIOTRONIK; 2: AHA (Associate Editor, Circulation Arrhythmia & Electrophysiology)
Phillip Cuculich, MD Washington University School of Medicine, St. Louis, Missouri 2: Medtronic None None None None None None None
Andre d’Avila, MD, PhD Hospital Cardiologico SOS Cardio, Florianopolis, Brazil None None None None None None None None
Barbara J. Deal, MD, FACC Northwestern University Feinberg School of Medicine, Chicago, Illinois None None None None None None None None
Paolo Della Bella, MD Ospedale San Raffaele, Milan, Italy 2: Biosense Webster; 2: Boston Scientific; 3: Abbott None None 2: Medtronic; 3: Abbott Vascular; 3: Biosense Webster; 3: BIOTRONIK; 4: Boston Scientific None None None None
Thomas Deneke, MD, PhD, FHRS Herz- und Gefäß-Klinik, Bad Neustadt, Germany None None None None None None None None
Timm-Michael Dickfeld, MD, PhD, FACC, FHRS University of Maryland, Baltimore, Maryland 1: Abbott Laboratories; 1: Biosense Webster; 1: Impulse Dynamics; 1: Philips None 1: GE Healthcare None None None None None
Claudio Hadid, MD Hospital General de Agudos Cosme Argerich, Buenos Aires, Argentina None None None None None None None None
Haris M. Haqqani, MBBS, PhD, FHRS University of Queensland, The Prince Charles Hospital, Chermside, Australia 0: Abbott Laboratories; 0: Boston Scientific; 0: Medtronic None 3: Biosense Webster None None None None None
G. Neal Kay, MD, CCDS University of Alabama at Birmingham, Birmingham, Alabama None None None None None None None None
Rakesh Latchamsetty, MD, FHRS University of Michigan, Ann Arbor, Michigan None 1: BIOTRONIK None None None None None None
Francis Marchlinski, MD, FHRS University of Pennsylvania, Philadelphia, Pennsylvania 1: Abbott; 1: Biosense Webster; 1: Boston Scientific; 1: Medtronic; 2: BIOTRONIK None 1: Abbott; 4: Biosense Webster 2: BIOTRONIK; 2: Boston Scientific; 4: Abbott; 4: Biosense Webster; 4: Medtronic None None None None
John M. Miller, MD, FHRS Indiana University School of Medicine, Krannert Institute of Cardiology, Indianapolis, Indiana 1: Abbott Laboratories; 1: Biosense Webster; 1: Boston Scientific; 1: BIOTRONIK; 1: Medtronic None None 3: Biosense Webster; 3: Boston Scientific; 3: Medtronic None None 1: Elsevier None
Akihiko Nogami, MD, PhD University of Tsukuba, Ibaraki, Japan 1: Abbott Laboratories None 4: Medtronic None None None None None
Akash R. Patel, MD, FHRS, CEPS-P University of California San Francisco Benioff Children’s Hospital, San Francisco, California None None None None None None None None
Rajeev Kumar Pathak, MBBS, PhD, FHRS Australian National University, Canberra Hospital, Canberra, Australia 1: BIOTRONIK 1: Medtronic None None None None None None
Luis C. Saenz Morales, MD CardioInfantil Foundation, Cardiac Institute, Bogota, Columbia None None None None None None None None
Pasquale Santangeli, MD, PhD University of Pennsylvania, Philadelphia, Pennsylvania 1: Abiome; 1: Baylis Medical; 1: Biosense Webster; 1: Medtronic; 1: Stereotaxis; 2: Abbott Laboratories None None None None None None None
John L. Sapp, Jr., MD, FHRS Queen Elizabeth II Health Sciences Centre, Halifax, Canada 1: Abbott Vascular; 1: Biosense Webster; 1: Medtronic None 4: Abbott Vascular; 5: Biosense Webster None None None 1: Biosense Webster None
Andrea Sarkozy, MD, PhD, FEHRA University Hospital Antwerp, University of Antwerp, Antwerp, Belgium 1: Biosense Webster; 1: BIOTRONIK None None None None None None 0: EHRA Board member
Kyoko Soejima, MD Kyorin University School of Medicine, Tokyo, Japan 2: Abbott Laboratories; 2: Boehringer Ingelheim 3: Medtronic None None None None None None
William G. Stevenson, MD, FHRS Vanderbilt University Heart and Vascular Center, Nashville, Tennessee 1: Abbot; 1: BIOTRONIK; 1: Boston Scientific; 1: Medtronic None None None None None 0: Biosense Webster; 0: Brigham and Women’s Hospital None
Usha B. Tedrow, MD, MS, FHRS Brigham and Women’s Hospital, Boston, Massachusetts 1: Abbott; 1: Biosense Webster; 1: Medtronic None None None None None None None
Wendy S. Tzou, MD, FHRS University of Colorado Denver, Aurora, Colorado 1: Abbott; 1: Biosense Webster; 1: BIOTRONIK; 1: Boston Scientific; 1: Medtronic None None None None None None None
Niraj Varma, MD, PhD Cleveland Clinic, Cleveland, Ohio 1: BIOTRONIK; 1: Medtronic None 3: Abbott None None None None None
Katja Zeppenfeld, MD, PhD, FESC, FEHRA Leiden University Medical Center, Leiden, the Netherlands 1: Abbott None 5: Biosense Webster 3: Biosense Webster None None None None

Number value: 0 = $0; 1 = ≤ $10,000; 2 = > $10,000 to ≤ $25,000; 3 = > $25,000 to ≤ $50,000; 4 = > $50,000 to ≤ $100,000; 5 = > $100,000.

ABIM = American Board of Internal Medicine; ACC = American College of Cardiology; AHA = American Heart Association; APHRS = Asia Pacific Heart Rhythm Society; EHRA = European Heart Rhythm Association; LAHRS = Latin American Heart Rhythm Society; NIH = National Institutes of Health.

*

Research and fellowship support are classed as programmatic support. Sources of programmatic support are disclosed but are not regarded as a relevant relationship with industry for writing group members or reviewers.